Featured Research

from universities, journals, and other organizations

Grow Old In Good Health: Vast Disparity Between European Countries

Date:
November 26, 2008
Source:
University of Leicester
Summary:
Although life expectancy is constantly growing in the countries of the EU, living longer isn't always the same as living well, and knowing to what age someone will live in good health remains a different question altogether.

Healthy life years at age 50 for EU countries.
Credit: EU-SILC 2005

Although life expectancy is constantly growing in the countries of the EU, living longer isn’t always the same as living well, and knowing to what age someone will live in good health remains a different question altogether.

Carol Jagger, Professor of Epidemiology at the University of Leicester, is part of the European Health Expectancy Monitoring Unit (EHEMU), who have undertaken a research project on healthy life expectancy within the EU.

Using a new indicator called Healthy Life Years, they found that in 2005 life expectancy in the EU was 78 years on average for men and 83 for women, while men live on average without any health problems up to 67 years and women to 69 years.

Great disparities persist, however, between the countries of the EU, and the differences in Healthy Life Years are much greater than differences in life expectancy.

The lowest ‘years of healthy life’ is seen in Estonia, where the age is 59 years for men and 61 for women. In Denmark, by contrast, those values rise to 73 years for men and 74 years for women. The UK is higher than the European average with figures of 69 years and 9 months for men and 70 years and 9 months for women.

These results are correlated with the overall wealth of the different countries as measured by GDP and the average level of health spending by the countries on older people. In general, a strong GDP and higher health spending are associated with more Healthy Life Years at age 50.

For men, long periods out of work (over 12 months) and poorer education were equally responsible for fewer Healthy Life Years.

The disparities observed are even stronger among the last ten countries to have joined the EU. For most of these countries, the age of retirement is higher than or coincides with the average age at which people can hope to live without health problems.

Carol Jagger commented: “Without an improvement in the state of health of older people, it will be difficult to raise the retirement age or bring more older workers into the workforce for certain EU countries.”

Partner institutions in the research project are: the University of Leicester; the French Institute for Demographic Studies (INED); The Scientific Institute of Public Health, Belgium; the Erasmus Medical Center, University Medical Center Rotterdam, Netherlands; and the French Institute of Health and Medical Research, (Inserm)


Story Source:

The above story is based on materials provided by University of Leicester. Note: Materials may be edited for content and length.


Cite This Page:

University of Leicester. "Grow Old In Good Health: Vast Disparity Between European Countries." ScienceDaily. ScienceDaily, 26 November 2008. <www.sciencedaily.com/releases/2008/11/081117082429.htm>.
University of Leicester. (2008, November 26). Grow Old In Good Health: Vast Disparity Between European Countries. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/11/081117082429.htm
University of Leicester. "Grow Old In Good Health: Vast Disparity Between European Countries." ScienceDaily. www.sciencedaily.com/releases/2008/11/081117082429.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins